Throughout the last three months, 17 analysts have evaluated 3M MMM, offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 5 | 6 | 3 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 2 | 1 | 0 | 0 | 0 |
| 2M Ago | 1 | 1 | 3 | 1 | 0 |
| 3M Ago | 0 | 2 | 3 | 2 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $107.29, a high estimate of $140.00, and a low estimate of $78.00. This upward trend is apparent, with the current average reflecting a 4.95% increase from the previous average price target of $102.23.
Investigating Analyst Ratings: An Elaborate Study
The perception of 3M by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Nigel Coe | Wolfe Research | Announces | Outperform | $125.00 | - |
| Andrew Obin | B of A Securities | Raises | Buy | $120.00 | $105.00 |
| Julian Mitchell | Barclays | Raises | Overweight | $118.00 | $112.00 |
| Jeffrey Sprague | Vertical Research | Raises | Buy | $140.00 | $92.00 |
| Wesley Brooks | HSBC | Raises | Buy | $115.00 | $91.13 |
| Andrew Kaplowitz | Citigroup | Raises | Neutral | $100.00 | $98.00 |
| Deane Dray | RBC Capital | Raises | Underperform | $87.00 | $78.00 |
| Damian Karas | UBS | Raises | Neutral | $100.00 | $98.00 |
| Stephen Tusa | JP Morgan | Raises | Overweight | $111.00 | $110.00 |
| Stephen Tusa | JP Morgan | Lowers | Neutral | $110.00 | $118.00 |
| Andrew Kaplowitz | Citigroup | Raises | Neutral | $98.00 | $95.31 |
| Deane Dray | RBC Capital | Lowers | Underperform | $78.00 | $84.00 |
| Julian Mitchell | Barclays | Lowers | Overweight | $107.00 | $126.00 |
| Andrew Obin | B of A Securities | Lowers | Neutral | $100.00 | $110.00 |
| Brett Linzey | Mizuho | Maintains | Neutral | $105.00 | $105.00 |
| Deane Dray | RBC Capital | Maintains | Underperform | $84.00 | - |
| Julian Mitchell | Barclays | Raises | Overweight | $126.00 | $111.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to 3M. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of 3M compared to the broader market.
- Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.
Capture valuable insights into 3M's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on 3M analyst ratings.
Delving into 3M's Background
3M is a multinational conglomerate that has operated since 1902, when it was known as Minnesota Mining and Manufacturing. The company is well known for its research and development laboratory and it leverages its science and technology across multiple product categories. As of the second quarter of 2024, 3M is organized across three business segments: safety and industrial, transportation and electronics, and consumer. Nearly 50% of the company's revenue comes from outside the Americas, with the safety and industrial segment constituting a plurality of net sales. Many of the company's tens of thousands of products touch and concern a variety of consumers and end markets.
Understanding the Numbers: 3M's Finances
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Negative Revenue Trend: Examining 3M's financials over 3 months reveals challenges. As of 31 March, 2024, the company experienced a decline of approximately -0.35% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: 3M's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 11.6%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): 3M's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 19.19%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): 3M's ROA excels beyond industry benchmarks, reaching 1.75%. This signifies efficient management of assets and strong financial health.
Debt Management: With a high debt-to-equity ratio of 4.55, 3M faces challenges in effectively managing its debt levels, indicating potential financial strain.
How Are Analyst Ratings Determined?
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
